Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Is it me, or.....

I don't know where to start. You made my point well except you presented your case without any "IMO" and that tells me all I need to know. You believe the divy paid is

Oh wait, here's one for you, you

...paying divys at this stage in ptsc makes no sense...

IMO, Howerver, those divys are more likely the reason the stock is not at~$0.30 than at the current price as every run up will be met with S & L selling warrants. That's S & L's responsibility -- diversify for their best interest while assuming the least possible risk.

You never answered my question:

Why would a company use PR to tout itself when it is possible that same company may be looking for another business model in less than 60 days or so?

All of your company specific points would still be valid should PTSC win via Markman results. If they do not win, what was gained by the PR.

Of course, if you really believe PTSC shoudl be a $10 stock now with a different management team than the one that brought the company pps from <$0.10 to over $0.50 pps, that's all I need to know.

As for you being a whiner, if the shoe fits....

Have a nice day,

John

Share
New Message
Please login to post a reply